Cargando…
Super-enhancers in esophageal carcinoma: Transcriptional addictions and therapeutic strategies
The tumorigenesis of esophageal carcinoma arises from transcriptional dysregulation would become exceptionally dependent on specific regulators of gene expression, which could be preferentially attributed to the larger non-coding cis-regulatory elements, i.e. super-enhancers (SEs). SEs, large genomi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647064/ https://www.ncbi.nlm.nih.gov/pubmed/36387198 http://dx.doi.org/10.3389/fonc.2022.1036648 |
_version_ | 1784827303100940288 |
---|---|
author | Shi, Yang Wang, Meiqi Liu, Dan Ullah, Saif Ma, Xing Yang, Huiyu Liu, Bingrong |
author_facet | Shi, Yang Wang, Meiqi Liu, Dan Ullah, Saif Ma, Xing Yang, Huiyu Liu, Bingrong |
author_sort | Shi, Yang |
collection | PubMed |
description | The tumorigenesis of esophageal carcinoma arises from transcriptional dysregulation would become exceptionally dependent on specific regulators of gene expression, which could be preferentially attributed to the larger non-coding cis-regulatory elements, i.e. super-enhancers (SEs). SEs, large genomic regulatory entity in close genomic proximity, are underpinned by control cancer cell identity. As a consequence, the transcriptional addictions driven by SEs could offer an Achilles’ heel for molecular treatments on patients of esophageal carcinoma and other types of cancer as well. In this review, we summarize the recent findings about the oncogenic SEs upon which esophageal cancer cells depend, and discuss why SEs could be seen as the hallmark of cancer, how transcriptional dependencies driven by SEs, and what opportunities could be supplied based on this cancer-specific SEs. |
format | Online Article Text |
id | pubmed-9647064 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96470642022-11-15 Super-enhancers in esophageal carcinoma: Transcriptional addictions and therapeutic strategies Shi, Yang Wang, Meiqi Liu, Dan Ullah, Saif Ma, Xing Yang, Huiyu Liu, Bingrong Front Oncol Oncology The tumorigenesis of esophageal carcinoma arises from transcriptional dysregulation would become exceptionally dependent on specific regulators of gene expression, which could be preferentially attributed to the larger non-coding cis-regulatory elements, i.e. super-enhancers (SEs). SEs, large genomic regulatory entity in close genomic proximity, are underpinned by control cancer cell identity. As a consequence, the transcriptional addictions driven by SEs could offer an Achilles’ heel for molecular treatments on patients of esophageal carcinoma and other types of cancer as well. In this review, we summarize the recent findings about the oncogenic SEs upon which esophageal cancer cells depend, and discuss why SEs could be seen as the hallmark of cancer, how transcriptional dependencies driven by SEs, and what opportunities could be supplied based on this cancer-specific SEs. Frontiers Media S.A. 2022-10-27 /pmc/articles/PMC9647064/ /pubmed/36387198 http://dx.doi.org/10.3389/fonc.2022.1036648 Text en Copyright © 2022 Shi, Wang, Liu, Ullah, Ma, Yang and Liu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Shi, Yang Wang, Meiqi Liu, Dan Ullah, Saif Ma, Xing Yang, Huiyu Liu, Bingrong Super-enhancers in esophageal carcinoma: Transcriptional addictions and therapeutic strategies |
title | Super-enhancers in esophageal carcinoma: Transcriptional addictions and therapeutic strategies |
title_full | Super-enhancers in esophageal carcinoma: Transcriptional addictions and therapeutic strategies |
title_fullStr | Super-enhancers in esophageal carcinoma: Transcriptional addictions and therapeutic strategies |
title_full_unstemmed | Super-enhancers in esophageal carcinoma: Transcriptional addictions and therapeutic strategies |
title_short | Super-enhancers in esophageal carcinoma: Transcriptional addictions and therapeutic strategies |
title_sort | super-enhancers in esophageal carcinoma: transcriptional addictions and therapeutic strategies |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647064/ https://www.ncbi.nlm.nih.gov/pubmed/36387198 http://dx.doi.org/10.3389/fonc.2022.1036648 |
work_keys_str_mv | AT shiyang superenhancersinesophagealcarcinomatranscriptionaladdictionsandtherapeuticstrategies AT wangmeiqi superenhancersinesophagealcarcinomatranscriptionaladdictionsandtherapeuticstrategies AT liudan superenhancersinesophagealcarcinomatranscriptionaladdictionsandtherapeuticstrategies AT ullahsaif superenhancersinesophagealcarcinomatranscriptionaladdictionsandtherapeuticstrategies AT maxing superenhancersinesophagealcarcinomatranscriptionaladdictionsandtherapeuticstrategies AT yanghuiyu superenhancersinesophagealcarcinomatranscriptionaladdictionsandtherapeuticstrategies AT liubingrong superenhancersinesophagealcarcinomatranscriptionaladdictionsandtherapeuticstrategies |